Adaptive Biotechnologies (ADPT) Scheduled to Post Earnings on Thursday

Adaptive Biotechnologies (NASDAQ:ADPT) is set to release its earnings data after the market closes on Thursday, November 7th. Analysts expect Adaptive Biotechnologies to post earnings of ($0.30) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Adaptive Biotechnologies Stock Performance

NASDAQ:ADPT opened at $5.26 on Tuesday. Adaptive Biotechnologies has a fifty-two week low of $2.28 and a fifty-two week high of $5.80. The company has a market cap of $775.69 million, a price-to-earnings ratio of -3.58 and a beta of 1.45. The stock has a fifty day moving average price of $4.73 and a 200-day moving average price of $4.07.

Analysts Set New Price Targets

ADPT has been the subject of a number of recent research reports. BTIG Research upped their target price on Adaptive Biotechnologies from $7.00 to $8.00 and gave the stock a “buy” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. boosted their target price on Adaptive Biotechnologies from $5.00 to $6.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $6.25.

About Adaptive Biotechnologies

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system.